Moreover, it has been reported that patients with mutations may respond differently to treatments depending on the mutation class
Moreover, it has been reported that patients with mutations may respond differently to treatments depending on the mutation class. Colorectal cancer (CRC) is one of the most common cancers, with an associated mortality rate of 9.2% that makes it the second leading cause of cancer-associated deaths (1). Early-stage CRC can be curable under surgery, whereas…
Read more